Founded in January 2017, HEM Pharma Inc. is a South Korean biotechnology company specializing in microbiome-based solutions. The company focuses on developing probiotics, antibiotics, and other products aimed at personalized healthcare and live biotherapeutic products (LBP). HEM Pharma conducts research to understand the relationship between diseases and the human body's microbiota, providing optimal solutions for individuals.

Personalized Pharmaceutical Metal-Analytical Screening (PMAS) Technology: HEM Pharma utilizes PMAS technology to offer customized healthcare solutions based on individual microbiome analysis. ​ Live Biotherapeutic Products (LBP) Discovery Platform: The company provides services including disease biomarker verification, disease-specific animal model design, finished drug production, and microbial safety evaluation.

Private

Biotech